Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Royal Medical Center vs RxSpan MD

By GLP-1 ScorecardUpdated

Royal Medical CenterFactor scores not reassessed.
Site position #510

Lower score

RxSpan MD
Site position #4

Higher score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 49.4/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

RxSpan MD does not publish a tirzepatide price, so its RxSpan MD review sets out what it does disclose, while the Royal Medical Center review explains the conditions attached to Royal Medical Center's figure. The tirzepatide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.

If neither one fits, Royal Medical Center vs Sunlight.com and RxSpan MD vs Shapely compare each of them with another graded program, and the list of alternatives to Royal Medical Center ranks the programs closest to Royal Medical Center on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +64
22
86
Dose & formulationRxSpan MD +47
42
89
Clinical oversightRxSpan MD +26
62
88
Labs & monitoringRoyal Medical Center +3
86
83
FulfillmentRxSpan MD +41
48
89
Contract termsRoyal Medical Center +2
55
53
Royal Medical Center · top barRxSpan MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricRoyal Medical CenterRxSpan MD
WeighScore49.4/10084.3/100
GradeCB
Site position#510#4
SemaglutideNot disclosedCurrent compounded quote unconfirmed
TirzepatideNot disclosed by drug (compounded GLP-1 from $67 a month)Current compounded quote unconfirmed
CoverageCoverage not publishedConfirm treatment availability during intake
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedNot confirmed
Royal Medical Center

Site position #510 · C

Factor scores not reassessed.

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

What to consider

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard